Recruiting Pulmonary Hypertension Studies in Milwaukee
About Pulmonary Hypertension Clinical Trials in Milwaukee
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 13 pulmonary hypertension clinical trials recruiting participants in Milwaukee, WI. These studies are seeking a combined 1,109 participants. Research is being sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Medical College of Wisconsin, Miltenyi Biomedicine GmbH and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Milwaukee — FAQ
Are there pulmonary hypertension clinical trials in Milwaukee?
Yes, there are 13 pulmonary hypertension clinical trials currently recruiting in Milwaukee, WI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Milwaukee?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Milwaukee research site will contact you about next steps.
Are clinical trials in Milwaukee free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Milwaukee studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 13 active trials in Milwaukee are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated July 17, 2026 from ClinicalTrials.gov